Alpine Immune Sciences Announces Participation in January Investor Conferences
January 04 2022 - 4:05PM
Business Wire
Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading
clinical-stage immunotherapy company focused on developing
innovative treatments for cancer and autoimmune and inflammatory
diseases, today announced that members of its management team will
present at the following investor conferences in January 2022:
H.C. Wainwright BIOCONNECT Virtual
Conference Date: Monday, January 10, 2022 Time: Available on
demand beginning 7:00 a.m. ET/4:00 a.m. PT Event: Company
Presentation
J.P. Morgan Healthcare Conference
Date: Thursday, January 13, 2022 Time: 12:00 p.m. ET/9:00 a.m. PT
Event: Company Presentation
Webcasts of the H.C. Wainwright, and J.P. Morgan presentations
will be available online in the investor relations section of the
company’s website at https://ir.alpineimmunesciences.com/events. A
replay of the presentations will be available on the company
website for 90 days following the webcast.
About Alpine Immune Sciences, Inc.
Alpine Immune Sciences, Inc. is committed to leading a new wave
of immune therapeutics. With world-class research and development
capabilities, a highly productive scientific platform, and a proven
management team, Alpine is seeking to create first- or
best-in-class multifunctional immunotherapies via unique protein
engineering technologies to improve patients’ lives. Alpine has
entered into strategic collaborations with leading global
biopharmaceutical companies and has a diverse pipeline of clinical
and preclinical candidates in development. For more information,
visit www.alpineimmunesciences.com. Follow @AlpineImmuneSci on
Twitter and LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220104005826/en/
Investor Relations Alex Sharif Director, Investor
Relations and Corporate Development Alpine Immune Sciences, Inc
206-788-4545 ir@alpineimmunesciences.com
Media Relations Kelli Perkins Red House
Kelli@redhousecomms.com
Alpine Immune Sciences (NASDAQ:ALPN)
Historical Stock Chart
From Apr 2024 to May 2024
Alpine Immune Sciences (NASDAQ:ALPN)
Historical Stock Chart
From May 2023 to May 2024